HEALTHCARE
Global Genetic Engineering Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Genetic Engineering Market, By Product (Biochemical, Genetic Markers), Devices (PCR, Gene Gun, Gel Assemblies), Technique (Gene Splicing, Artificial Selection, Recombinant DNA Technology, Synthesizing DNA, Gene Editing, Other), Application (Agriculture, Bt- Cotton, Golden Rice, Others, Medical Industry, Recombinant Proteins, Recombinant Antibodies, Forensic Science, Others), End-User (Biotechnology Companies, Pharmaceutical Manufacturers, Academic and Research Institutions, Other), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
Market Dynamics
- Increasing demand for genetically modified crops
- Rising prevalence of genetic disorders
- Potential environmental impacts
- High costs associated with research and development
- Emerging markets in developing countries
- Innovations in gene therapy and biopharmaceuticals
- Intellectual property issues
- Public perception and acceptance
SEGMENTATION
- Product
- Biochemical
- Genetic Markers
- Devices
- PCR
- Gene Gun
- Gel Assemblies
- Technique
- Gene Splicing
- Artificial Selection
- Recombinant DNA Technology
- Synthesizing DNA
- Gene Editing
- Other
- Application
- Agriculture
- Bt- Cotton
- Golden Rice
- Others
- Medical Industry
- Recombinant Proteins
- Recombinant Antibodies
- Forensic Science
- Others
- End-User
- Biotechnology Companies
- Pharmaceutical Manufacturers
- Academic and Research Institutions
- Other
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Thermo Fisher Scientific Inc.
- Lonza
- Cibus
- Recombinetics Inc.
- Sangamo
- Merck KGaA
- Precision Biosciences
- OriGene Technologies Inc.
- Intellia Therapeutics Inc.
- Caribou Biosciences Inc.
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Genetic Engineering Market, by Product
- 3.2 Global Genetic Engineering Market, by Devices
- 3.3 Global Genetic Engineering Market, by Technique
- 3.4 Global Genetic Engineering Market, by Application
- 3.5 Global Genetic Engineering Market, by End-User
- 3.6 Global Genetic Engineering Market, by Geography
- 3.7 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Advancements in CRISPR/Cas9 technology
- 5.1.2 Increasing applications in agriculture and healthcare
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Increasing demand for genetically modified crops
- 5.2.2 Rising prevalence of genetic disorders
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Potential environmental impacts
- 5.3.2 High costs associated with research and development
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Emerging markets in developing countries
- 5.4.2 Innovations in gene therapy and biopharmaceuticals
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Intellectual property issues
- 5.5.2 Public perception and acceptance
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL GENETIC ENGINEERING MARKET, BY PRODUCT
- 6.1 Product Summary
- 6.2 Market Attractive Index
- 6.3 Global Genetic Engineering Market, by Product (2019-2032)
- SECTION 7 - GLOBAL GENETIC ENGINEERING MARKET, BY DEVICES
- 7.1 Devices Summary
- 7.2 Market Attractive Index
- 7.3 Global Genetic Engineering Market, by Devices (2019-2032)
- SECTION 8 - GLOBAL GENETIC ENGINEERING MARKET, BY TECHNIQUE
- 8.1 Technique Summary
- 8.2 Market Attractive Index
- 8.3 Global Genetic Engineering Market, by Technique (2019-2032)
- SECTION 9 - GLOBAL GENETIC ENGINEERING MARKET, BY APPLICATION
- 9.1 Application Summary
- 9.2 Market Attractive Index
- 9.3 Global Genetic Engineering Market, by Application (2019-2032)
- SECTION 10 - GLOBAL GENETIC ENGINEERING MARKET, BY END-USER
- 10.1 End-User Summary
- 10.2 Market Attractive Index
- 10.3 Global Genetic Engineering Market, by End-User (2019-2032)
- SECTION 11 - GLOBAL GENETIC ENGINEERING MARKET, BY GEOGRAPHY
- 11.1 Regional Summary
- 11.2 Market Attractive Index
- 11.3 Global Genetic Engineering Market, by Geography (2019-2032)
- SECTION 12 - NORTH AMERICA GENETIC ENGINEERING MARKET
- 12.1 North America Summary
- 12.2 Market Attractive Index
- 12.3 North America Genetic Engineering Market, by Product (2019-2032)
- 12.4 North America Genetic Engineering Market, by Devices (2019-2032)
- 12.5 North America Genetic Engineering Market, by Technique (2019-2032)
- 12.6 North America Genetic Engineering Market, by Application (2019-2032)
- 12.7 North America Genetic Engineering Market, by End-User (2019-2032)
- 12.12 North America Genetic Engineering Market, by Country (2019-2032)
- 12.12.1 U.S.
- 12.12.2 Canada
- 12.12.3 Mexico
- 12.12.4 Rest of North America
- SECTION 13 - EUROPE GENETIC ENGINEERING MARKET
- 13.1 Europe Summary
- 13.2 Market Attractive Index
- 13.3 Europe Genetic Engineering Market, by Product (2019-2032)
- 13.4 Europe Genetic Engineering Market, by Devices (2019-2032)
- 13.5 Europe Genetic Engineering Market, by Technique (2019-2032)
- 13.6 Europe Genetic Engineering Market, by Application (2019-2032)
- 13.7 Europe Genetic Engineering Market, by End-User (2019-2032)
- 13.8 Europe Genetic Engineering Market, by Country (2019-2032)
- 13.8.1 Germany
- 13.8.2 U.K.
- 13.8.3 France
- 13.8.4 Italy
- 13.8.5 Spain
- 13.8.6 Russia
- 13.8.7 The Netherlands
- 13.8.8 Belgium
- 13.8.9 Turkey
- 13.8.10 Rest of Europe
- SECTION 14 - ASIA-PACIFIC GENETIC ENGINEERING MARKET
- 14.1 Asia-Pacific Summary
- 14.2 Market Attractive Index
- 14.3 Asia-Pacific Genetic Engineering Market, by Product (2019-2032)
- 14.4 Asia-Pacific Genetic Engineering Market, by Devices (2019-2032)
- 14.5 Asia-Pacific Genetic Engineering Market, by Technique (2019-2032)
- 14.6 Asia-Pacific Genetic Engineering Market, by Application (2019-2032)
- 14.7 Asia-Pacific Genetic Engineering Market, by End-User (2019-2032)
- 14.8 Asia-Pacific Genetic Engineering Market, by Country (2019-2032)
- 14.8.1 China
- 14.8.2 India
- 14.8.3 Japan
- 14.8.4 South Korea
- 14.8.5 Singapore
- 14.8.6 Malaysia
- 14.8.7 Australia
- 14.8.8 Thailand
- 14.8.9 Philippines
- 14.8.10 Rest of Asia-Pacific
- SECTION 15 - SOUTH AMERICA GENETIC ENGINEERING MARKET
- 15.1 South America Summary
- 15.2 Market Attractive Index
- 15.3 South America Genetic Engineering Market, by Product (2019-2032)
- 15.4 South America Genetic Engineering Market, by Devices (2019-2032)
- 15.5 South America Genetic Engineering Market, by Technique (2019-2032)
- 15.6 South America Genetic Engineering Market, by Application (2019-2032)
- 15.7 South America Genetic Engineering Market, by End-User (2019-2032)
- 15.8 South America Genetic Engineering Market, by Country (2019-2032)
- 15.8.1 Brazil
- 15.8.2 Argentina
- 15.8.3 Chile
- 15.8.4 Colombia
- 15.8.5 Rest of South America
- SECTION 16 - MIDDLE EAST AND AFRICA GENETIC ENGINEERING MARKET
- 16.1 Middle East and Africa Summary
- 16.2 Market Attractive Index
- 16.3 Middle East and Africa Genetic Engineering Market, by Product (2019-2032)
- 16.4 Middle East and Africa Genetic Engineering Market, by Devices (2019-2032)
- 16.5 Middle East and Africa Genetic Engineering Market, by Technique (2019-2032)
- 16.6 Middle East and Africa Genetic Engineering Market, by Application (2019-2032)
- 16.7 Middle East and Africa Genetic Engineering Market, by End-User (2019-2032)
- 16.8 Middle East and Africa Genetic Engineering Market, by Country (2019-2032)
- 16.8.1 Kingdom of Saudi Arabia
- 16.8.2 South Africa
- 16.8.3 U.A.E.
- 16.8.4 Egypt
- 16.8.5 Rest of Middle East and Africa
- SECTION 17 - COMPANY SHARE ANALYSIS
- 17.1 Global Genetic Engineering Market, Company Share Analysis
- 17.2 North America Genetic Engineering Market, Company Share Analysis
- 17.3 Europe Genetic Engineering Market, Company Share Analysis
- 17.4 Asia-Pacific Genetic Engineering Market, Company Share Analysis
- SECTION 18 - COMPANY PROFILES
- 18.1 Thermo Fisher Scientific Inc.
- 18.1.1 Company Snapshot
- 18.1.2 Financial Overview
- 18.1.3 Product Portfolio
- 18.1.4 Recent Developments
- 18.2 Lonza
- 18.2.1 Company Snapshot
- 18.2.2 Financial Overview
- 18.2.3 Product Portfolio
- 18.2.4 Recent Developments
- 18.3 Cibus
- 18.3.1 Company Snapshot
- 18.3.2 Financial Overview
- 18.3.3 Product Portfolio
- 18.3.4 Recent Developments
- 18.4 Recombinetics Inc.
- 18.4.1 Company Snapshot
- 18.4.2 Financial Overview
- 18.4.3 Product Portfolio
- 18.4.4 Recent Developments
- 18.5 Sangamo
- 18.5.1 Company Snapshot
- 18.5.2 Financial Overview
- 18.5.3 Product Portfolio
- 18.5.4 Recent Developments
- 18.6 Merck KGaA
- 18.6.1 Company Snapshot
- 18.6.2 Financial Overview
- 18.6.3 Product Portfolio
- 18.6.4 Recent Developments
- 18.7 Precision Biosciences
- 18.7.1 Company Snapshot
- 18.7.2 Financial Overview
- 18.7.3 Product Portfolio
- 18.7.4 Recent Developments
- 18.8 OriGene Technologies Inc.
- 18.8.1 Company Snapshot
- 18.8.2 Financial Overview
- 18.8.3 Product Portfolio
- 18.8.4 Recent Developments
- 18.9 Intellia Therapeutics Inc.
- 18.9.1 Company Snapshot
- 18.9.2 Financial Overview
- 18.9.3 Product Portfolio
- 18.9.4 Recent Developments
- 18.10 Caribou Biosciences Inc.
- 18.10.1 Company Snapshot
- 18.10.2 Financial Overview
- 18.10.3 Product Portfolio
- 18.10.4 Recent Developments
- SECTION 19 - RELATED REPORTS
- SECTION 20 - DISCLAIMER
RESEARCH METHODOLOGY
RESEARCH AND DATA COLLECTION
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.